Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
-0.0%
1w
2.1%
1m
0.9%
3m
8.1%
6m
23.7%
1y
32.0%
all
45.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,552 -0.0%
2,364
2,883
Company Overview

Sales
11,018 Cr
Growth: 15.5%
Profit after Tax
2,115 Cr
Growth: 7.8%
Large Cap
1,02,231 Cr
P/E: 48.4x
Industry P/E: 36.0x
Fundamentals

Sales (Cr) ₹ 11,018
Growth 15.5%
EBITDA 24.8%
P/S 9.3x
Dividend 0.0%
P/E 48.4x
Book Value ₹ 263
PEG Ratio 3.1x
ROE 21.9%
P/B 9.7x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.